Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Cue Biopharma, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 80 | 77 | −3 |
| Shares | 14.9M | 16.4M | +1.50M (+10.1%) |
| Value | $39.3M | $31.0M | −$8.33M (−21.2%) |
New holders (7)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 19,974 | $37.8K | 0.00% |
| Acadian Asset Management LLC | 12,439 | $23.0K | 0.00% |
| Toroso Investments, LLC | 11,612 | $21.9K | 0.00% |
| Simplex Trading, LLC | 9,531 | $18.0K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 7 | $13 | 0.00% |
| Assetmark, Inc | 2 | $4 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (10)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Annandale Capital, LLC | 65,000 | $172.0K |
| Jane Street Group, LLC | 54,629 | $144.2K |
| AQR Capital Management LLC | 22,340 | $59.0K |
| Price T Rowe Associates Inc | 18,231 | $49.0K |
| XTX Topco Ltd | 15,304 | $40.4K |
| Caption Management, LLC | 14,000 | $37.0K |
| Advisory Services Network, LLC | 200 | $528 |
| Russell Investments Group, Ltd. | 172 | $454 |
| Farther Finance Advisors, LLC | 22 | $58 |
| Nisa Investment Advisors, LLC | 20 | $53 |